1. IMPORTANT: In the next few weeks, we will be upgrading the message board software. We expect minimal downtime during the upgrade, and we will attempt to complete this during low-traffic hours. We will post an exact time several days ahead of the switch.

    In preparation for the upgrade, we will be performing board maintenance, such as moving boards to Lost Civilizations where appropriate. Lost Civilizations is a category for companies that have either been dissolved or acquired. The boards serve as both an archive of the old company posts, as well as a place for former employees to reminisce or reconnect, as they will remain open for posting. We may also remove some board threads that have been inactive for several years.
    Dismiss Notice

Eli Lilly Gears Up for Donanemab Adcomm as FDA Ponders Changes to Format

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 6, 2024 at 12:12 PM.

  1. #1 cafead, May 6, 2024 at 12:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,420
    Likes Received:
    3
    via On April 29, the FDA announced it would hold a listening session to discuss the composition of advisory committees and ways to ensure public awareness and understanding of their role in the regulatory process. The news comes as the agency gears up for arguably the biggest advisory committee meeting of the year, regarding Eli Lilly’s highly anticipated Alzheimer’s drug donanemab.

    article source
     
    Quote

Reply to Thread